URIST MARSHALL (EVP & Co-Head Research & Inv.) sold 33.3% of their position (20K shares) of ROYALTY PHARMA PLC on the open market
Open‑market sale worth $790.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/20/2026ACC: 0001838139-26-000006
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
-20K
Net shares
Net seller
$790.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
20K disposed
Non-Derivative Transactions1
Class A Ordinary Shares
Indirect
Shares
−20K
Price / share
$39.52
Trade value
$790.35K
% of position
33.3%
1/16/2026
60K→40K
Total
Net shares
−20K
Net value
-$790.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Indirect | 1/16/2026 | S · Sale | −20K | $39.52 | $790.35K | 33.3% | 60K | 40K |
| Total | −20K | -$790.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Class A Ordinary Shares
IndirectShares owned19.02K
Class A Ordinary Shares
DirectShares owned7.40K
Total
7.40K direct·19.02K indirect26.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 19.02K | Indirect |
| Class A Ordinary Shares | 7.40K | Direct |
| Total | 26.42K | 7.40K direct·19.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported